Mu Yang

Molly Yang has a diverse work experience. From 2009 to 2010, they were an Undergraduate Researcher at Shenyang Pharmaceutical University and a Pharmacy Intern at the First Affiliated Hospital of China Medical University. In 2010, they earned their Ph.D. from Michigan Technological University. From 2016 to 2017, they were a Sr. Research Associate at BioMarin Pharmaceutical Inc. From 2017 to 2023, they were at Levena Biopharma, where they held various roles, including Sr Scientist/Sr Manager, ADC process development, Sr. Scientist, ADC Process Development, Scientist II, ADC Process Development, and Scientist, ADC Process Development. In 2023, they began working as the Associate Director, CMC at Bright Peak Therapeutics.

Molly Yang earned a Doctor of Philosophy (Ph.D.) in Biochemistry from Michigan Technological University in 2015. Prior to that, they earned a Bachelor's degree in Pharmacy (Clinical pharmacy) from Shenyang Pharmaceutical University in 2010.